Загрузка...
The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer
BACKGROUND: Treatment of locally advanced squamous cell carcinomas of the head and neck (SCCHN) remains unsatisfactory. Although the addition of concurrent radiochemotherapy (RCT) or the combination of radiotherapy with blockade of the epidermal growth factor receptor (EGFR) have improved outcomes o...
Сохранить в:
| Опубликовано в: : | Cancers Head Neck |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6460729/ https://ncbi.nlm.nih.gov/pubmed/31093338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41199-016-0009-6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|